Mallinckrodt Specialty Generics
August 10th 2014Mallinckrodt Pharmaceuticals started formulating and supplying industry-leading pharmaceutical products more than 146 years ago. Continually building on its legacy, the company employs a vertically integrated process to ensure quality control during every step of the product’s development from active ingredient processing through formulation, manufacturing, and distribution.
FDA approves another antibiotic for hard-to-treat skin infections
August 7th 2014FDA has approved oritavancin (Orbactiv, The Medicines Company) for injection for the treatment of adults with acute bacterial skin and skin structure infections (ABSSSIs) caused by susceptible designated Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA).